Histone Arginine Methylation Regulates Pluripotency in the Early
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Four Enzymes Cooperate to Displace Histone H1 During the First Minute of Hormonal Gene Activation
Downloaded from genesdev.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation Guillermo Pablo Vicent,1,2 A. Silvina Nacht,1 Jofre Font-Mateu, Giancarlo Castellano, Laura Gaveglia, Cecilia Ballare´, and Miguel Beato Centre de Regulacio´ Geno` mica (CRG), Universitat Pompeu Fabra (UPF), E-08003 Barcelona, Spain Gene regulation by external signals requires access of transcription factors to DNA sequences of target genes, which is limited by the compaction of DNA in chromatin. Although we have gained insight into how core histones and their modifications influence this process, the role of linker histones remains unclear. Here we show that, within the first minute of progesterone action, a complex cooperation between different enzymes acting on chromatin mediates histone H1 displacement as a requisite for gene induction and cell proliferation. First, activated progesterone receptor (PR) recruits the chromatin remodeling complexes NURF and ASCOM (ASC-2 [activating signal cointegrator-2] complex) to hormone target genes. The trimethylation of histone H3 at Lys 4 by the MLL2/MLL3 subunits of ASCOM, enhanced by the hormone-induced displacement of the H3K4 demethylase KDM5B, stabilizes NURF binding. NURF facilitates the PR-mediated recruitment of Cdk2/CyclinA, which is required for histone H1 displacement. Cooperation of ATP-dependent remodeling, histone methylation, and kinase activation, followed by H1 displacement, is a prerequisite for the subsequent displacement of histone H2A/H2B catalyzed by PCAF and BAF. Chromatin immunoprecipitation (ChIP) and sequencing (ChIP-seq) and expression arrays show that H1 displacement is required for hormone induction of most hormone target genes, some of which are involved in cell proliferation. -
Inferring Causal Relationships Among Different Histone Modifications and Gene Expression
Downloaded from genome.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Inferring Causal Relationships among Different Histone Modifications and Gene Expression Hong Yu*, Shanshan Zhu*, Bing Zhou*, Huiling Xue and Jing-Dong J. Han Chinese Academy of Sciences Key Laboratory of Molecular Developmental Biology, Center for Molecular Systems Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Datun Road, Beijing, 100101, China * These authors contributed equally to this work. Correspondence should be addressed to J.-D.J.H ([email protected]). Running title: histone modification and gene expression network Keywords: histone modification, gene expression, Bayesian network, causal relationship, epigenetics 1 Downloaded from genome.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract Histone modifications are major epigenetic factors regulating gene expression. They play important roles in maintaining stem cell pluripotency and in cancer pathogenesis. Different modifications may combine to form complex ‘histone codes’. Recent high throughput technologies, such as ‘ChIP-chip’ and ‘ChIP-seq’, have generated high resolution maps for many histone modifications on the human genome. Here we use these maps to build a Bayesian network to infer causal and combinatorial relationships among histone modifications and gene expression. A pilot network derived by the same method among polycomb group (PcG) genes and H3K27 trimethylation is accurately supported by current literature. Our unbiased network model among histone modifications is also well supported by cross validation results. It not only confirmed already known relationships, such as those of H3K27me3 to gene silencing, H3K4me3 to gene activation, and the effect of bivalent modification of both H3K4me3 and H3K27me3, but also identified many other relationships that may predict new epigenetic interactions important in epigenetic gene regulation. -
Anti-H3r2me2(Asym) Antibody
FOR RESEARCH USE ONLY! 01/20 Anti-H3R2me2(asym) Antibody CATALOG NO.: A2025-100 (100 µl) BACKGROUND DESCRIPTION: Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene is intronless and encodes a replication-dependent histone that is a member of the histone H3 family. Transcripts from this gene lack poly A tails; instead, they contain a palindromic termination element. This gene is located separately from the other H3 genes that are in the histone gene cluster on chromosome 6p22-p21.3. H3.4; H3/g; H3FT; H3t; HIST3H3; Histone H3; HIST1H3A ALTERNATE NAMES: ANTIBODY TYPE: Polyclonal HOST/ISOTYPE: Rabbit / IgG IMMUNOGEN: A synthetic methylated peptide targeting residues around Arginine 2 of human Histone H3 MOLECULAR WEIGHT: 17 kDa PURIFICATION: Affinity purified FORM: Liquid FORMULATION: In PBS with 0.02% sodium azide, 50% glycerol, pH 7.3 SPECIES REACTIVITY: Human, Mouse, Rat STORAGE CONDITIONS: Store at -20ºC. Avoid freeze / thaw cycles APPLICATIONS AND USAGE: WB 1:500 - 1:2000, IHC 1:50 - 1:200, IF 1:50 - 1:200 Note: This information is only intended as a guide. The optimal dilutions must be determined by the user Western blot analysis of H3R2me2(asym) expression in Dot-blot analysis of methylation peptides using Anti- HeLa cells and H3 protein. -
Searching for Inhibitors of the Protein Arginine Methyl Transferases: Synthesis and Characterisation of Peptidomimetic Ligands
SEARCHING FOR INHIBITORS OF THE PROTEIN ARGININE METHYL TRANSFERASES: SYNTHESIS AND CHARACTERISATION OF PEPTIDOMIMETIC LIGANDS by ASTRID KNUHTSEN B. Sc., Aarhus University, 2009 M. Sc., Aarhus University, 2012 A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in THE FACULTY OF GRADUATE AND POSTDOCTORAL STUDIES (Pharmaceutical Sciences) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) March 2016 © Astrid Knuhtsen, 2016 UNIVERSITY OF COPENH AGEN FACULTY OF HEALTH A ND MEDICAL SCIENCES PhD Thesis Astrid Knuhtsen Searching for Inhibitors of the Protein Arginine Methyl Transferases: Synthesis and Characterisation of Peptidomimetic Ligands December 2015 This thesis has been submitted to the Graduate School of The Faculty of Health and Medical Sciences, University of Copenhagen ii Thesis submission: 18th of December 2015 PhD defense: 11th of March 2016 Astrid Knuhtsen Department of Drug Design and Pharmacology Faculty of Health and Medical Sciences University of Copenhagen Universitetsparken 2 DK-2100 Copenhagen Denmark and Faculty of Pharmaceutical Sciences University of British Columbia 2405 Wesbrook Mall BC V6T 1Z3, Vancouver Canada Supervisors: Principal Supervisor: Associate Professor Jesper Langgaard Kristensen Department of Drug Design and Pharmacology, University of Copenhagen, Denmark Co-Supervisor: Associate Professor Daniel Sejer Pedersen Department of Drug Design and Pharmacology, University of Copenhagen, Denmark Co-Supervisor: Assistant Professor Adam Frankel Faculty of Pharmaceutical -
Asymmetric Expression of Lincget Biases Cell Fate in Two-Cell Mouse Embryos
UC Riverside UC Riverside Previously Published Works Title Asymmetric Expression of LincGET Biases Cell Fate in Two-Cell Mouse Embryos. Permalink https://escholarship.org/uc/item/3100h0cm Journal Cell, 175(7) ISSN 0092-8674 Authors Wang, Jiaqiang Wang, Leyun Feng, Guihai et al. Publication Date 2018-12-01 DOI 10.1016/j.cell.2018.11.039 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Article Asymmetric Expression of LincGET Biases Cell Fate in Two-Cell Mouse Embryos Graphical Abstract Authors Jiaqiang Wang, Leyun Wang, Guihai Feng, ..., Zhonghua Liu, Wei Li, Qi Zhou Correspondence [email protected] (W.L.), [email protected] (Q.Z.) In Brief An endogenous retrovirus-associated nuclear long noncoding RNA biases cell fate in mouse two-cell embryos. Highlights Data Resources d LincGET is asymmetrically expressed in the nucleus of two- GSE110419 to four-cell mouse embryos d LincGET overexpression biases blastomere fate toward inner cell mass (ICM) d LincGET physically binds to CARM1 d LincGET/CARM1 activates ICM-specific genes Wang et al., 2018, Cell 175, 1887–1901 December 13, 2018 ª 2018 Elsevier Inc. https://doi.org/10.1016/j.cell.2018.11.039 Article Asymmetric Expression of LincGET Biases Cell Fate in Two-Cell Mouse Embryos Jiaqiang Wang,1,2,3,4,8 Leyun Wang,1,8 Guihai Feng,1,8 Yukai Wang,1,8 Yufei Li,1,2 Xin Li,5,6 Chao Liu,1,2 Guanyi Jiao,1,2 Cheng Huang,1,2 Junchao Shi,7 Tong Zhou,7 Qi Chen,7 Zhonghua Liu,4 Wei Li,1,2,3,* and Qi Zhou1,2,3,9,* 1State Key Laboratory of Stem Cell and Reproductive -
Symmetric-Di-Methyl-Histone H3 (Arg8) Rabbit
Symmetric -Di-methyl-Histone H3 (Arg8) rabbit pAb ( H3R8me2(sy) pAb) www.ptm-biolab.com.cn Cat#: PTM-672 [email protected] Species: Rabbit 0571-2883 3567 Size: 100 μl Form: supplied in liquid form Recommend Species Swissprot Molecular Application Immunogen dilution Reactivity ID Weight H3R8me2(sy) WB, Dot, ELISA 1:2000 for WB H, M, R, Mk P68431 17 KDa -KLH **Species reactivity is determined by WB. Kept at -20oC after reconstituted. *** Anti-rabbit secondary antibodies must be used to detect this antibody. Source/Purification: This product is produced by immunizing rabbits with a synthetic di-methyl(sy) peptide corresponding to residues surrounding Arg8 of human histone H3. Antibodies are purified by protein A-conjugated agarose followed by di-methylated(sy) histone H3 (Arg8) peptide affinity chromatography. Recommended Applications: ELISA, Dot blot, Western blot. Recommended antibody dilution: WB: 1:2000 NOTE: For WB, incubate membrane with diluted antibody in 5% nonfat milk, 1 x TBS, 0.1% Tween- 20 for two hours at room temperature with gentle shaking. Prepare working dilution immediately before use. Use at an assay dependent concentration. Optimal dilutions/concentrations should be determined by the end user. Not yet tested in other applications Scientific Description: Proteins post-translational Modification (PTM) is an important reversible event controlling protein activity. The amino-terminal tails of core histones undergo multiple modifications in multiple sites, termed as “histone code” or “epigenetic code”. Lysine methylation or arginine methylation in core histones is a major determinant for the formation of active and inactive regions of the genome and therefore plays vital roles in multiple cellular events. -
BMC Genomics Biomed Central
BMC Genomics BioMed Central Research article Open Access Determination of enriched histone modifications in non-genic portions of the human genome Jeffrey A Rosenfeld1,2,3, Zhibin Wang4, Dustin E Schones4, Keji Zhao4, Rob DeSalle3 and Michael Q Zhang*1 Address: 1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 USA, 2Department of Biology, New York University, New York, NY USA, 3American Museum of Natural History, New York, NY USA and 4Laboratory of Molecular Immunology, National Heart, Lung and Blood Institute, NIH, Bethesda, MD USA Email: Jeffrey A Rosenfeld - [email protected]; Zhibin Wang - [email protected]; Dustin E Schones - [email protected]; Keji Zhao - [email protected]; Rob DeSalle - [email protected]; Michael Q Zhang* - [email protected] * Corresponding author Published: 31 March 2009 Received: 8 September 2008 Accepted: 31 March 2009 BMC Genomics 2009, 10:143 doi:10.1186/1471-2164-10-143 This article is available from: http://www.biomedcentral.com/1471-2164/10/143 © 2009 Rosenfeld et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Chromatin immunoprecipitation followed by high-throughput sequencing (ChIP- seq) has recently been used to identify the modification patterns for the methylation and acetylation of many different histone tails in genes and enhancers. Results: We have extended the analysis of histone modifications to gene deserts, pericentromeres and subtelomeres. Using data from human CD4+ T cells, we have found that each of these non- genic regions has a particular profile of histone modifications that distinguish it from the other non- coding regions. -
Le G´Enome En Action
LEGENOME´ EN ACTION SEQUENC´ ¸ AGE HAUT DEBIT´ ET EPIG´ ENOMIQUE´ Epig´enomique´ ? IFT6299 H2014 ? UdeM ? Mikl´osCs}ur¨os Regulation´ d’expression la transcription d’une region´ de l’ADN necessite´ ? liaisons proteine-ADN´ (facteur de transcription et son site reconnu) ? accessibilite´ de la chromatine REVIEWS Identification of regions that control transcription An initial step in the analysis of any gene is the identifi- cation of larger regions that might harbour regulatory control elements. Several advances have facilitated the prediction of such regions in the absence of knowl- edge about the specific characteristics of individual cis- Chromatin regulatory elements. These tools broadly fall into two categories: promoter (transcription start site; TSS) and enhancer detection. The methods are influenced Distal TFBS by sequence conservation between ORTHOLOGOUS genes (PHYLOGENETIC FOOTPRINTING), nucleotide composition and the assessment of available transcript data. Functional regulatory regions that control transcrip- tion rates tend to be proximal to the initiation site(s) of transcription. Although there is some circularity in the Co-activator complex data-collection process (regulatory sequences are sought near TSSs and are therefore found most often in these regions), the current set of laboratory-annotated regula- tory sequences indicates that sequences near a TSS are Transcription more likely to contain functionally important regulatory initiation complex Transcription controls than those that are more distal. However, specifi- initiation cation of the position of a TSS can be difficult. This is fur- ther complicated by the growing number of genes that CRM Proximal TFBS selectively use alternative start sites in certain contexts. Underlying most algorithms for promoter prediction is a Figure 1 | Components of transcriptional regulation. -
Histone Methylation by PRC2 Is Inhibited by Active Chromatin Marks
Histone methylation by PRC2 is inhibited by active chromatin marks Inauguraldissertation zur Erlangung der Würde eines Doktors der Philosophie vorgelegt der Philosophisch–Naturwissenschaftlichen Fakultät der Universität Basel von Frank W. Schmitges aus Deutschland Basel, 2013 Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät auf Antrag von Prof. Dr. Susan Gasser, Dr. Nicolas Thomä, Dr. Wolfgang Fischle. Basel, den 20. September 2011 Prof. Dr. Susan Gasser (Fakultätsverantwortliche) Prof. Dr. Martin Spiess (Dekan) Table of Contents Abbreviations............................................................................................................................ 6 1. Summary ............................................................................................................................... 8 2. Introduction .......................................................................................................................... 9 2.1 Chromatin ......................................................................................................................... 9 2.2 Epigenetics ........................................................................................................................ 9 2.3 Mechanisms of epigenetic regulation ............................................................................. 10 2.3.1 DNA methylation ..................................................................................................... 11 2.3.2 Histone methylation ................................................................................................ -
Anti-Symmetric Di-Methyl-Histone H3 (Arg2) Mouse Mab
Anti-Symmetric Di-Methyl-Histone H3 (Arg2) Mouse mAb Catalog # PTM-693 General Information Images Host species Mouse Dot Blot Clonality Monoclonal Blocking buffer: 5% NFDM/TBST Primary ab dilution: 1:1000 Clone number / Primary ab incubation condition: 2 hours at room temperature Synonym H3R2me2 (sy) Secondary ab: Goat Anti-Mouse IgG H&L Immunogen UniProt MW (kDa) Applications (HRP) species Immunogen peptide quantity: 1 ng, 4 ng, 16 ng Human P68431 17 WB Exposure time: 60 s The list of peptides is included in the table below: No. Peptide No. Peptide Product Usage Information Lane 1 H3R2me2 (sy) Lane 2 H3R2me1 Application Dilution Recommended species Lane 3 H3R2me2 (asy) Lane 4 H3K4ac Human, Mouse, Rat, Lane 5 H3K4cr Lane 6 H3K4hib WB 1:500-1:2000 Lane 7 H3K4me1 Lane 8 H3K4me2 Chlorocebus aethiops Lane 9 H3K4me3 Lane 10 H3R8me1 Lane 11 H3R8me2 Lane 12 H3R8me2 (asy) Properties Lane 13 H3R2un Storage Store at -20 °C. Avoid freeze / thaw cycles. WB Blocking buffer: 5% NFDM/TBST Stability Stable for 12 months from date of receipt / reconstitution Primary ab dilution: 1:2000 Constituents PBS, Glycerol, BSA Primary ab incubation condition: 2 hours at room temperature Purity Antibodies are purified by protein G-conjugated agarose Secondary ab: Goat Anti-Mouse IgG H&L followed by di-methylated(sy) histone H3 (Arg2) peptide (HRP) Lysate: MCF-7, BRL, COS-7 affinity chromatography. Protein loading quantity: 20 μg Isotype IgG Exposure time: 60 s Predicted MW: 17 kDa Target Information Observed MW: 17 kDa Function Histone post-translational modifications (PTMs) are key mechanisms of epigenetics that modulate chromatin Research Use structures, termed as “histone code”. -
Establishment and Optimization of the Chrop Approach, Combining Chip and MS-Based Proteomics
PhD degree in Molecular Medicine European School of Molecular Medicine (SEMM), University of Milan and University of Naples “Federico II” Faculty of Medicine Settore disciplinare: BIO/10 Establishment and optimization of the ChroP approach, combining ChIP and MS-based proteomics, for the characterization of the chromatome at distinct functional domains Monica Soldi IFOM-IEO Campus, Milan Matricola n. R08407 Supervisor: Dr. Tiziana Bonaldi IFOM-IEO Campus, Milan Added co-Supervisor: Dr. Gioacchino Natoli IFOM-IEO Campus, Milan Anno accademico 2011-2012 To my family: Andrea and Paolo! 1 TABLE OF CONTENT FIGURE AND TABLE INDEX ....................................................................................... 5 LIST OF ABBREVIATIONS ....................................................................................... 8 1. ABSTRACT .............................................................................................................. 10 2. INTRODUCTION .................................................................................................... 13 2.1. Chromatin, epigenetics and histone post-translational modifications ............... 13 2.2. Mass Spectrometry analysis and MS-based proteomics ...................................... 17 2.2.1. Basic concepts of Mass Spectrometry........................................................... 19 2.2.2. Different MS approaches for hPTMs analysis: from “Bottom Up” to “Top Down”, via “Middle Down” .................................................................................. 25 -
Crosstalk Between Histone Modifications Indicates That
9348–9360 Nucleic Acids Research, 2017, Vol. 45, No. 16 Published online 20 June 2017 doi: 10.1093/nar/gkx550 Crosstalk between histone modifications indicates that inhibition of arginine methyltransferase CARM1 activity reverses HIV latency Zheng Zhang1,†, Bryan C. Nikolai1,†, Leah A. Gates1, Sung Yun Jung2, Edward B. Siwak3, Bin He1,4, Andrew P. Rice3, Bert W. O’Malley1 and Qin Feng1,* 1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA, 2Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA, 3Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA and 4Department of Medicine-Hematology & Oncology, Baylor College of Medicine, Houston, TX, USA Received February 06, 2017; Revised May 25, 2017; Editorial Decision June 13, 2017; Accepted June 15, 2017 ABSTRACT INTRODUCTION In eukaryotic cells, the gene expression status Human immunodeficiency virus (HIV) is a retrovirus that is strictly controlled by epigenetic modifications causes acquired immunodeficiency syndrome. HIV infec- on chromatin. The repressive status of chromatin tion of CD4+ helper T lymphocytes is a multistep process, largely contributes to HIV latency. Studies have involving fusion and entry through interaction with CD4 re- shown that modification of histone H3K27 acts as ceptor and CCR5 co-receptor, reverse transcription of HIV viral RNA into double-stranded viral DNA, and integra- a key molecular switch for activation or suppression tion of viral DNA into